Dr. Alan B. Colowick M.D. serves as
Independent Director of the Company. Dr. Colowick has served as a Partner at Sofinnova Investment, Inc., a clinical stage life sciences venture capital firm. From February 2010 to April 2017, Dr. Colowick held various positions, including Executive Vice President, at Celgene Corporation, a pharmaceutical company. From February 2008 to January 2010, Dr. Colowick served as the Chief Executive Officer of Gloucester Pharmaceuticals Inc., an early stage cancer pharmaceutical company, until its acquisition by Celgene Corporation in January 2010. From October 2006 to February 2008, Dr. Colowick served as President, Oncology at Geron Corporation, an early stage pharmaceutical company. Earlier in his career, Dr. Colowick served in various capacities at Amgen Inc., a biopharmaceutical company. Dr. Colowick has served on the board of directors of Human Longevity, Inc., a genomics-based health intelligence company, since June 2016, and has served on the board of directors of Principia Biopharma Inc., a biopharmaceutical company, since February 2017. Dr. Colowick previously served on the board of directors of Achaogen, Inc., a biopharmaceutical company, from August 2015 to August 2017, and on the board of directors of Dimension Therapeutics, Inc., a biopharmaceutical company, from August 2015 to November 2017. Dr. Colowick holds a B.S. in Molecular Biology from the University of Colorado, an M.D. from Stanford University School of Medicine, and an M.P.H. from the Harvard School of Public Health. Dr. Colowick was selected to serve on our board of directors because of his educational background in sciences, as well as financial understanding of the biotechnology industry gained from his investing experience.
What is Alan Colowick's net worth?
The estimated net worth of Alan Colowick is at least $750,375.00 as of July 1st, 2020. Dr. Colowick owns 7,500 shares of Principia Biopharma stock worth more than $750,375 as of May 16th. This net worth estimate does not reflect any other investments that Dr. Colowick may own. Learn More about Alan Colowick's net worth.
How old is Alan Colowick?
How do I contact Alan Colowick?
Has Alan Colowick been buying or selling shares of Principia Biopharma?
Alan Colowick has not been actively trading shares of Principia Biopharma during the last quarter. Most recently, Alan Colowick sold 7,500 shares of the business's stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $60.00, for a transaction totalling $450,000.00. Following the completion of the sale, the director now directly owns 7,500 shares of the company's stock, valued at $450,000. Learn More on Alan Colowick's trading history.
Who are Principia Biopharma's active insiders?